Mascoma Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
925
-2
| -0.2% | -$251 | 0.03% | 118 |
|
|
2025
Q1 | $127K | Hold |
927
| – | – | 0.03% | 117 |
|
|
2024
Q4 | $142K | Buy |
927
+2
| +0.2% | +$306 | 0.04% | 111 |
|
|
2024
Q3 | $179K | Hold |
925
| – | – | 0.04% | 98 |
|
|
2024
Q2 | $214K | Hold |
925
| – | – | 0.06% | 92 |
|
|
2024
Q1 | $199K | Hold |
925
| – | – | 0.06% | 95 |
|
|
2023
Q4 | $239K | Hold |
925
| – | – | 0.07% | 90 |
|
|
2023
Q3 | $238K | Hold |
925
| – | – | 0.07% | 91 |
|
|
2023
Q2 | $254K | Sell |
925
-9
| -1% | -$2.47K | 0.08% | 88 |
|
|
2023
Q1 | $284K | Buy |
934
+925
| +10,278% | +$281K | 0.08% | 96 |
|
|
2022
Q4 | $2.49K | Hold |
9
| – | – | ﹤0.01% | 554 |
|
|
2022
Q3 | $2K | Hold |
9
| – | – | ﹤0.01% | 552 |
|
|
2022
Q2 | $2K | Hold |
9
| – | – | ﹤0.01% | 562 |
|
|
2022
Q1 | $2K | Hold |
9
| – | – | ﹤0.01% | 550 |
|
|
2021
Q4 | $2K | Hold |
9
| – | – | ﹤0.01% | 494 |
|
|
2021
Q3 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 402 |
|
|
2021
Q2 | – | Sell |
-9
| Closed | -$3K | – | 137 |
|
|
2021
Q1 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 399 |
|
|
2017
Q3 | – | Sell |
-40
| Closed | -$11K | – | 398 |
|
|
2017
Q2 | $11K | Buy |
+40
| New | +$11K | 0.01% | 277 |
|